uBriGene Biosciences
PrivateLast Round
VC Round
Dec 24, 2024
Total Funding Raised
$66M
Company Overview
uBriGene Biosciences is a biotechnology company that provides contract development and manufacturing organization (CDMO) services for the cell and gene therapy industry.
Sector
Healthcare & Life Sciences
Verticals
Pharma Supply Chain, Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
uBriGene Biosciences Comps
Public and private peers based on sector, stage, and business model.
uBriGene Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Dec 24, 2024 | ||||
| Series C Extension | Apr 19, 2023 | ||||
| Series C | Sep 27, 2022 | ||||
| Series B | Sep 16, 2021 | ||||
| Series A | Dec 16, 2020 | ||||
Angel | Oct 1, 2019 |
uBriGene Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BGI Co-Win | Series C |
| IDG Capital | Series C, Series B |
| 中信金石投资有限公司 | Series C |
| Innovator Capital | Series C |
| Wenzhou State-owned Financial Capital Management | Series C |
| Beijing Fangfu Venture Capital Management | Series C Extension, Series C, Series A, Series B |
| Huagai Capital | Series C, Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 8, 2025
Monthly visitors increased 46% MoM.
- Jun 2, 2025
Monthly visitors grew 43% MoM, reaching 2K.
uBriGene Biosciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about uBriGene Biosciences's valuation, stock price, and market status.
